FPHAX: Fidelity® Select Pharmaceuticals Port

Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

Channels

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

FPHAX Fidelity® Select Pharmaceuticals Port

  • Fund
  • FPHAX
  • Price as of: Dec 12, 2019
  • $23.90
    + $0.15 + 0.63%

Profile

FPHAX - Profile

Vitals

  • YTD Return 24.1%
  • 3 Yr Annualized Return 11.6%
  • 5 Yr Annualized Return 1.3%
  • Net Assets $756 M
  • Holdings in Top 10 69.8%

52 WEEK LOW AND HIGH

$23.90
$18.19
$23.90

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.80%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 55.00%

TRADING FEES

  • Max Redemption Fee 0.75%

Min Investment

  • Standard (Taxable) $0
  • IRA $2,500

Fund Classification


Distributions

  • YTD Total Return 24.1%
  • 3 Yr Annualized Total Return 12.8%
  • 5 Yr Annualized Total Return 5.6%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 1.48%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name
    Fidelity® Select Pharmaceuticals Portfolio
  • Fund Family Name
    Fidelity Investments
  • Inception Date
    Jun 18, 2001
  • Shares Outstanding
    N/A
  • Share Class
    No Load
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Karim Suwwan de Felipe

Fund Description

The Fidelity Select Pharmaceuticals Portfolio (FPHAX) is an actively managed fund that focuses on the health care sector. FPHAX hones in on those firms that research and develop drugs, including traditional pharmaceutical firms and biotech drug makers. The fund can hold domestic or foreign stocks of any size. FPHAX’s managers focus on innovation as well as profits when selecting the fund’s underlying portfolio.

Despite its low costs, FPHAX’s extremely narrow focus places it in the satellite position camp within a broader equity portfolio. The fund is run by several Fidelity offices.


Get Updates About FPHAX

Sign up for Advisor Access to receive email updates about FPHAX competitors, news, CE accredited webcasts and more.

Please Enter Your Email
Please Select Your Advisor Type

Categories

Fund Company Quick Screens

FPHAX - Fund Company Quick Screens


Performance

FPHAX - Performance

Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 24.1% 3.4% 49.1% 33.33%
1 Yr 15.2% -12.6% 29.3% 19.66%
3 Yr 11.6%* -14.0% 28.3% 33.03%
5 Yr 1.3%* -11.5% 15.4% 50.96%
10 Yr 8.3%* -1.8% 16.8% 62.50%

* Annualized

Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
2018 3.8% -25.3% 21.5% 3.60%
2017 8.9% -10.8% 43.9% 78.90%
2016 -17.2% -31.6% 6.9% 59.43%
2015 -3.8% -20.4% 13.8% 64.08%
2014 11.3% -5.8% 31.5% 70.83%

Total Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 24.1% 3.4% 49.1% 33.33%
1 Yr 15.2% -12.6% 38.1% 24.79%
3 Yr 12.8%* -14.0% 28.5% 30.28%
5 Yr 5.6%* -11.5% 17.0% 38.46%
10 Yr 13.6%* -1.8% 18.0% 38.64%

* Annualized

Total Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
2018 4.4% -25.3% 22.2% 4.50%
2017 10.7% -10.8% 45.8% 85.32%
2016 -16.3% -26.4% 8.7% 69.81%
2015 8.3% -16.6% 15.2% 28.16%
2014 24.6% -5.8% 36.7% 50.00%

NAV & Total Return History


Holdings

FPHAX - Holdings

Concentration Analysis

FPHAX Category Low Category High FPHAX % Rank
Net Assets 756 M 3.25 M 47.5 B 62.99%
Number of Holdings 63 26 388 77.95%
Net Assets in Top 10 502 M 913 K 17.4 B 38.58%
Weighting of Top 10 69.76% 21.3% 77.1% 1.57%

Top 10 Holdings

  1. AstraZeneca PLC ADR 12.54%
  2. Bristol-Myers Squibb Company 10.40%
  3. Johnson & Johnson 10.13%
  4. Sanofi SA ADR 8.44%
  5. Roche Holding AG Dividend Right Cert. 7.45%
  6. Eli Lilly and Co 5.08%
  7. Merck & Co Inc 4.58%
  8. Novartis AG ADR 4.44%
  9. Zoetis Inc Class A 3.91%
  10. Allergan PLC 2.79%

Asset Allocation

Weighting Return Low Return High FPHAX % Rank
Stocks
99.13% 90.21% 103.54% 37.01%
Cash
0.59% 0.00% 9.79% 70.87%
Other
0.28% -27.41% 5.17% 29.13%
Preferred Stocks
0.00% 0.00% 1.08% 16.54%
Convertible Bonds
0.00% 0.00% 1.54% 9.45%
Bonds
0.00% 0.00% 20.60% 8.66%

Stock Sector Breakdown

Weighting Return Low Return High FPHAX % Rank
Healthcare
99.09% 56.22% 99.75% 14.96%
Utilities
0.00% 0.00% 0.00% 0.79%
Technology
0.00% 0.00% 16.35% 33.86%
Real Estate
0.00% 0.00% 5.81% 9.45%
Industrials
0.00% 0.00% 2.40% 11.81%
Financial Services
0.00% 0.00% 5.93% 22.83%
Energy
0.00% 0.00% 0.43% 4.72%
Communication Services
0.00% 0.00% 1.02% 4.72%
Consumer Defense
0.00% 0.00% 34.83% 11.02%
Consumer Cyclical
0.00% 0.00% 10.49% 10.24%
Basic Materials
0.00% 0.00% 1.94% 26.77%

Stock Geographic Breakdown

Weighting Return Low Return High FPHAX % Rank
US
58.61% 58.61% 99.93% 100.00%
Non US
40.52% 0.00% 40.52% 0.79%

Expenses

FPHAX - Expenses

Operational Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.80% 0.10% 4.94% 82.91%
Management Fee 0.54% 0.09% 1.30% 4.72%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.01% 0.40% N/A

Sales Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee 0.75% 0.75% 2.00% 70.73%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 55.00% 0.00% 341.00% 75.42%

Distributions

FPHAX - Distributions

Dividend Yield Analysis

FPHAX Category Low Category High FPHAX % Rank
Dividend Yield 0.00% 0.00% 5.43% 16.54%

Dividend Distribution Analysis

FPHAX Category Low Category High Category Mod
Dividend Distribution Frequency Semi-Annually Annually Quarterly Annually

Net Income Ratio Analysis

FPHAX Category Low Category High FPHAX % Rank
Net Income Ratio 1.48% -2.24% 2.12% 1.71%

Capital Gain Distribution Analysis

FPHAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

FPHAX - Fund Manager Analysis

Managers

Karim Suwwan de Felipe


Start Date

Tenure

Tenure Rank

Jul 01, 2017

2.42

2.4%

Since joining Fidelity Investments in 2010, Mr. Suwwan de Felipe has worked as a research analyst and portfolio manager.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.34 22.22 9.78 19.59